Important Safety Information On The Association Of Zevalin (ibritumomab Tiuxetan) With Severe Mucocutaneous Reactions- Notice To Hospitals- Berlex Canada Inc.

Category: drug recall
Country: Canada
Agency: HC-DRUGS
Recall date: 2005-12-07
Status: Closed
Distribution: Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/5d93bb2b-2d08-440a-9503-70ce688d7691

Nibble requires JavaScript

Please enable JavaScript in your browser settings to use the app.